Impax Laboratories argued that Goodwin Procter shouldn't represent Teva Pharmaceuticals, because the firm had previously represented both Teva and Impax in an underlying case.
November 05, 2018 at 08:13 PM
1 minute read
The Pennsylvania Superior Court has rejected one pharmaceutical company’s effort to have Goodwin Procter disqualified from representing a rival in a Philadelphia case.
Impax Laboratories had appealed to the Superior Court over Goodwin Procter’s representation of Teva Pharmaceuticals. Teva is suing Impax for indemnification after Teva settled a false advertising case over a drug the two companies worked on together.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
